Is a Covid-19 vaccine before the end of the year still a reality?
company
Business of Health: Teaching an old drug new tricks
Typically, a promising new experimental drug arrives on the scene with a flourish. But sometimes, it’s a long and winding road.
OMRF collaborates with GSK to develop novel treatments for severe inflammatory diseases
This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.